Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,074,400 | 1,049,900 | 2,287,900 | 2,617,800 | 2,898,200 |
| Marketable Securities | N/A | N/A | 0 | 3,460,500 | 2,143,100 |
| Receivables | 1,999,700 | 2,100,000 | 1,781,400 | 1,685,900 | 1,634,400 |
| Inventories | 2,516,800 | 2,527,400 | 2,982,400 | 1,333,500 | 1,281,000 |
| Other current assets | 1,165,300 | 1,182,000 | 1,402,400 | 1,334,000 | 1,805,800 |
| TOTAL | $6,756,200 | $6,859,300 | $8,454,100 | $10,431,700 | $9,762,500 |
| Non-Current Assets | |||||
| PPE Net | 3,275,300 | 3,309,700 | 3,301,600 | 3,307,200 | 3,300,900 |
| Investments And Advances | 697,600 | 745,000 | 754,700 | 2,312,900 | 2,359,000 |
| Intangibles | 14,512,100 | 14,582,200 | 14,152,100 | 7,530,100 | 7,565,100 |
| Other Non-Current Assets | 1,326,400 | 1,348,600 | 1,530,700 | 1,574,900 | 1,610,900 |
| TOTAL | $19,811,400 | $19,985,500 | $19,739,100 | $14,725,100 | $14,835,900 |
| Total Assets | $26,567,600 | $26,844,800 | $28,193,200 | $25,156,800 | $24,598,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 387,000 | 403,300 | 440,100 | 445,400 | 491,200 |
| Accrued Expenses | 2,354,600 | 2,623,600 | 3,838,400 | 2,481,100 | 2,288,200 |
| TOTAL | $3,222,800 | $3,434,300 | $5,022,300 | $3,186,500 | $3,014,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,290,100 | 6,788,200 | 6,786,400 | 6,284,600 | 6,282,700 |
| Other Non-Current Liabilities | 1,183,600 | 1,181,900 | 1,176,900 | 1,079,600 | 1,262,800 |
| TOTAL | $8,131,800 | $8,611,100 | $8,691,200 | $7,509,800 | $7,796,500 |
| Total Liabilities | $11,354,600 | $12,045,400 | $13,713,500 | $10,696,300 | $10,811,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 145,597 | 145,361 | 144,898 | 144,823 | 144,742 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 18,021,000 | 17,627,600 | 17,377,900 | 17,446,000 | 16,854,400 |
| Other shareholders' equity | -160,600 | -153,800 | -163,500 | -179,300 | -181,700 |
| TOTAL | $15,213,000 | $14,799,400 | $14,479,700 | $14,460,500 | $13,787,000 |
| Total Liabilities And Equity | $26,567,600 | $26,844,800 | $28,193,200 | $25,156,800 | $24,598,400 |